HCW Biologics reported a gross margin of -69.25% and a net margin of -11,340.34% for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||
| Gross Margin | 57.40% | 36.74% | 20.00% | 20.00% | 29.92% | 19.33% | 20.49% | 19.08% | 54.56% | 29.15% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | -69.25% | ||
| EBT Margin | -60.33% | -773.36% | -223.98% | -429.49% | -13,022.01% | -739.56% | -606.42% | -813.20% | -665.09% | -2,471.61% | -917.77% | -863.18% | -43,862.27% | -29,430.99% | -21,909.50% | -17,304.52% | -3,849.90% | ||
| EBIT Margin | -60.33% | -773.36% | -222.20% | -422.45% | -12,798.92% | -724.22% | -595.23% | -813.31% | -665.09% | -2,445.81% | -864.06% | -797.23% | -38,811.49% | -52,886.67% | -21,095.26% | -16,519.15% | -2,335.57% | ||
| EBITDA Margin | -60.33% | -773.36% | -222.20% | -422.45% | -12,798.92% | -724.22% | -595.23% | -813.31% | -665.09% | -2,445.81% | -864.06% | -797.23% | -38,811.49% | -52,886.67% | -21,095.26% | -16,519.15% | -2,335.57% | ||
| Operating Margin | -60.33% | -773.36% | -222.20% | -422.45% | -12,798.92% | -724.22% | -595.23% | -813.31% | -665.09% | -2,445.81% | -864.06% | -797.23% | -38,811.49% | -52,886.67% | -21,095.26% | -16,519.15% | -2,335.57% | ||
| Net Margin | -65.99% | -773.25% | -223.98% | -429.49% | -13,022.01% | -739.56% | -606.42% | -813.20% | -665.09% | -2,469.11% | -915.12% | -854.42% | -43,862.27% | -184,450.82% | -29,183.24% | -12,832.14% | -11,340.34% | ||
| FCF Margin | -51.83% | -595.32% | -690.14% | -287.59% | -9,403.81% | -1,757.91% | -729.02% | -574.81% | -514.43% | -717.39% | -719.37% | -743.32% | -69,375.24% | -50,111.50% | -20,760.87% | -12,423.24% | |||
| Efficiency | |||||||||||||||||||
| Assets AverageAssets Avg. | 34.72M | 54.96M | 52.24M | 49.18M | 49.38M | 49.08M | 45.17M | 41.51M | 37.55M | 32.07M | 29.47M | 28.62M | 26.69M | 28.40M | 28.26M | 27.60M | 27.18M | 24.98M | 25.64M |
| Invested CapitalInvested Cap. | 51.19M | 49.00M | 82.11M | 39.09M | 35.08M | 30.32M | 19.77M | 17.14M | 3.72M | 9.17M | 13.24M | 11.61M | 13.16M | 11.51M | 16.38M | 20.55M | |||
| Asset Utilization RatioAsset Util. | 0.06 | 0.07 | 0.11 | 0.14 | 0.08 | 0.09 | 0.08 | 0.09 | 0.13 | 0.14 | 0.13 | 0.09 | 0.05 | 0.03 | 0.02 | 0.00 | 0.01 | ||
| Leverage & Solvency | |||||||||||||||||||
| Interest Coverage RatioInterest Cover | -124.90 | -59.99 | -57.37 | -47.22 | -53.16 | 0.01M | -94.80 | -16.09 | -12.09 | -7.68 | -15.15 | -25.91 | -21.03 | -31.49 | |||||
| Debt Ratio | 0.13 | 0.95 | 0.15 | 0.16 | 0.18 | 0.22 | 0.28 | 0.37 | 0.72 | 0.66 | 0.77 | 0.46 | 0.54 | 0.56 | 0.49 | ||||
| Times Interest Earned | -124.90 | -59.99 | -57.37 | -47.22 | -53.16 | 0.01M | -94.80 | -16.09 | -12.09 | -7.68 | -15.15 | -25.91 | -21.03 | -31.49 | |||||
| Valuation | |||||||||||||||||||
| Price to EarningsP/E | -3.84 | -2.29 | -7.92 | -3.74 | -3.38 | -1.99 | -1.54 | -2.82 | -2.20 | -0.72 | -1.47 | -0.27 | -0.87 | -0.99 | -38.02 | -0.10 | -0.37 | -0.10 | -0.43 |
| Price to SalesP/S | 5.22 | 28.94 | 7.57 | 8.54 | 200.08 | 20.86 | 13.35 | 5.83 | 9.79 | 6.59 | 7.97 | 8.46 | 0.02M | 179.37 | 106.75 | 12.56 | 48.88 | ||
| Price to BookP/B | 0.29 | 0.14 | 0.33 | 0.28 | 0.32 | 0.31 | 0.26 | 0.45 | 0.48 | 0.57 | 1.26 | -0.65 | -0.34 | -0.49 | -9.87 | -22.61 | -0.79 | 0.12 | 0.89 |
| Enterprise Value | -58.06M | -62.14M | -43.70M | -44.95M | -20.77M | -27.48M | -28.27M | -13.35M | 0.17M | 4.13M | 6.93M | 2.88M | 2.40M | -1.33M | 83.37M | -1.26M | 0.57M | -1.61M | 5.89M |
| EV to EBIT | 14.19 | 19.96 | 23.23 | 12.80 | 5.17 | 4.85 | 5.27 | 2.96 | -0.03 | -0.38 | -0.93 | -0.19 | -0.65 | 0.42 | -42.41 | 0.36 | -0.17 | 0.36 | -1.86 |
| EV to EBITDA | 14.19 | 19.96 | 23.23 | 12.80 | 5.17 | 4.85 | 5.27 | 2.96 | -0.03 | -0.38 | -0.93 | -0.19 | -0.65 | 0.42 | -42.41 | 0.36 | -0.17 | 0.36 | -1.86 |
| Market Capitalization | 15.72M | 7.26M | 16.29M | 13.14M | 13.69M | 11.45M | 8.38M | 12.99M | 11.39M | 7.72M | 11.03M | 4.08M | 3.40M | 3.34M | 84.48M | 1.17M | 1.67M | 0.34M | 6.63M |
| Price to FCFP/FCF | -3.07 | -2.14 | -10.08 | -4.86 | -1.10 | -2.97 | -2.13 | -1.19 | -1.83 | -1.01 | -1.90 | -0.92 | -1.11 | -1.14 | -24.04 | -0.36 | -0.51 | -0.10 | |
| EV to FCF | 11.33 | 18.29 | 27.05 | 16.63 | 1.66 | 7.12 | 7.18 | 1.22 | -0.03 | -0.54 | -1.20 | -0.65 | -0.78 | 0.45 | -23.73 | 0.39 | -0.18 | 0.48 | |
| EV to CFO | 11.34 | 18.40 | 27.45 | 16.71 | 8.97 | 7.25 | 7.77 | 1.42 | -0.03 | -1.06 | -1.92 | -0.59 | -0.82 | 0.47 | -23.73 | 0.39 | -0.18 | 0.48 | |
| Return Ratios | |||||||||||||||||||
| Return on Sales [ROS]ROS | -60.33% | -773.36% | -222.20% | -422.45% | -12,798.92% | -724.22% | -595.23% | -813.31% | -665.09% | -2,445.81% | -864.06% | -797.23% | -38,811.49% | -52,886.67% | -21,095.26% | -16,519.15% | -2,335.57% | ||
| Return on Capital Employed [ROCE]ROCE | -25.35% | -25.40% | -23.29% | -26.22% | -26.60% | -32.69% | -45.65% | -52.90% | -64.16% | -110.29% | -173.43% | -711.89% | 1,098.72% | 2,390.68% | -2,139.05% | -1,631.83% | -3,739.81% | -336.32% | -205.61% |
| Return on Assets [ROA]ROA | -23.60% | -24.32% | -22.66% | -25.61% | -25.43% | -30.98% | -41.57% | -47.88% | -55.91% | -81.09% | -95.15% | -135.30% | -140.40% | -106.04% | -87.89% | -41.56% | -40.39% | -49.00% | -59.43% |